
Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Signals
2026-05-19 08:07:04Tatva Chintan Pharma Chem Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and others, reflecting a nuanced market sentiment as the stock navigates recent volatility and sectoral pressures.
Read full news article
Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure
2026-05-18 13:31:13Shares of Tatva Chintan Pharma Chem Ltd declined sharply on 18 May 2026, hitting an intraday low of Rs 1,205, down 8.16% from the previous close. The stock underperformed its sector and the broader market, reflecting immediate selling pressure amid a cautious market environment.
Read full news article
Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-18 08:03:08Tatva Chintan Pharma Chem Ltd, a small-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Recent technical indicators, including MACD, Bollinger Bands, and KST, suggest improving price dynamics despite some mixed signals from moving averages and OBV. This nuanced technical picture, combined with the company’s performance relative to the Sensex, provides investors with a comprehensive view of its current market positioning.
Read full news articleAre Tatva Chintan Pharma Chem Ltd latest results good or bad?
2026-05-17 19:14:24Tatva Chintan Pharma Chem Ltd's latest financial results present a complex picture of operational performance. For the quarter ending March 2026, the company reported a net profit of ₹10.32 crores, which reflects a significant year-on-year growth of 901.94%. However, this figure represents a quarter-on-quarter decline of 31.97% from ₹15.17 crores in the previous quarter, primarily attributed to a notably high effective tax rate of 37.79%, which was substantially higher than the previous quarter's rate of 14.10%. In terms of revenue, Tatva Chintan achieved ₹134.14 crores, marking a year-on-year increase of 24.36% and a modest quarter-on-quarter growth of 2.14%. This revenue growth is indicative of the company's operational momentum, as it marks the seventh consecutive quarter of revenue growth, reaching its highest level in at least eight quarters. The operating profit margin also expanded to 20.97%, the h...
Read full news article
Tatva Chintan Q4 FY26: Stellar Turnaround Masks Profitability Concerns
2026-05-16 23:01:32Tatva Chintan Pharma Chem Ltd., a specialty chemicals manufacturer, delivered a remarkable turnaround in Q4 FY26 (January-March 2026), posting a consolidated net profit of ₹10.32 crores compared to a mere ₹1.03 crores in the same quarter last year—a staggering 901.94% year-on-year surge. The company's stock responded enthusiastically, trading at ₹1,312.00 on May 15, 2026, up 3.86% from the previous close, reflecting investor optimism about the recovery trajectory.
Read full news article
Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-13 08:05:48Tatva Chintan Pharma Chem Ltd, a specialty chemicals small-cap, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, reflecting a nuanced market sentiment as the stock navigates recent volatility.
Read full news article
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-05-12 10:11:08Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleWhen is the next results date for Tatva Chintan Pharma Chem Ltd?
2026-05-07 23:17:14The next results date for Tatva Chintan Pharma Chem Ltd is scheduled for 16 May 2026....
Read full news article
Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-06 08:06:18Tatva Chintan Pharma Chem Ltd, a small-cap player in the specialty chemicals sector, has recently exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key technical indicators, the stock’s price action and momentum metrics suggest a cautiously optimistic outlook for investors navigating the current market environment.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
17-May-2026 | Source : BSENewspaper Publication of Extract of Financial Results of the Company for the Quarter and Financial Year ended 31 March 2026.
Announcement under Regulation 30 (LODR)-Change in Management
16-May-2026 | Source : BSERe-appointment of Cost Auditor and Internal Auditor
Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On 31 March 2026
16-May-2026 | Source : BSEEnclosed
Corporate Actions
No Upcoming Board Meetings
Tatva Chintan Pharma Chem Ltd has declared 10% dividend, ex-date: 12 Sep 25
No Splits history available
No Bonus history available
No Rights history available






